Structured evidence table for Astaxanthin Cognition Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Astaxanthin Cognition Randomized Trial | The chemical diversity associated with these molecules is remarkable, comprising alkaloids, halogenated compounds, lactones, lipids, nucleosides, peptides, phenolics, polyketides, etc., some of which have very uncommon structural features. | 3 | Gomes-Bispo Ana (2026) | Marine Lipids and Alzheimer’s Disease: Biochemistry, Bioaccessibility/Bioavailability, Metabolism, and Health Effects |
| Astaxanthin Cognition Randomized Trial | On the other hand, it has been argued that there is insufficient available evidence to advise the use of any primary prevention therapy for AD. | 3 | Gomes-Bispo Ana (2026) | Marine Lipids and Alzheimer’s Disease: Biochemistry, Bioaccessibility/Bioavailability, Metabolism, and Health Effects |
| Astaxanthin Cognition Randomized Trial | This includes long-chain n-3 PUFA primary therapy, encompassing both eicosapentaenoic (EPA, 20:5 n-3) and docosahexaenoic acid (DHA, 22:6 n-3) [], found in fish and some dietary supplements []. | 3 | Gomes-Bispo Ana (2026) | Marine Lipids and Alzheimer’s Disease: Biochemistry, Bioaccessibility/Bioavailability, Metabolism, and Health Effects |
| Astaxanthin Cognition Randomized Trial | 1 2 3 4 5 Marine organisms are a very diverse group from both taxonomical and biochemical points of view []. | 3 | Gomes-Bispo Ana (2026) | Marine Lipids and Alzheimer’s Disease: Biochemistry, Bioaccessibility/Bioavailability, Metabolism, and Health Effects |
| Astaxanthin Cognition Randomized Trial | This review summarizes current evidence on nutritional compounds that target aging-related pathways, focusing on interventions that influence mitochondrial health, cognitive performance, immune function, metabolic regulation, and maintenance of muscle mass in older adults. | 4 | Kurtz JA (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits. |
| Astaxanthin Cognition Randomized Trial | Recent findings Evidence indicates that several targeted nutrients, including protein, probiotics, antioxidants, and emerging mitochondrial-support compounds, may contribute to healthy aging. | 4 | Kurtz JA (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits. |
| Astaxanthin Cognition Randomized Trial | A personalized, evidence-informed supplementation strategy integrated with exercise and balanced nutrition may help optimize physiological function in aging adults. | 4 | Kurtz JA (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits. |
| Astaxanthin Cognition Randomized Trial | Purpose of review Aging is marked by progressive physiological decline driven by chronic inflammation, mitochondrial dysfunction, and impaired metabolic and musculoskeletal resilience. | 4 | Kurtz JA (2026) | Targeted Supplementation and Nutritional Strategies for Healthy Aging: A Review of Physiological and Molecular Benefits. |
Source documents